Letter: Beyond Feasibility—The Need for Longer Duration and Composite NIT Endpoints in Biopsy‐Free MASH Trials: Authors' Reply
- 10 June 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 64 (2) , 301-302
Abstract
No abstract availableKeywords
Funding Information
- San Diego Digestive Diseases Research Center, School of Medicine, University of California, San Diego (P30 DK120515)
- National Center for Advancing Translational Sciences (5UL1TR001442)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061734)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK130190)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106419)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121378)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124318)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK120515)
- National Heart, Lung, and Blood Institute (P01HL147835)
This publication has 8 references indexed in Scilit:
- Letter: Beyond Feasibility: The Need for Longer Duration and Composite NIT Endpoints in Biopsy‐Free MASH TrialsAlimentary Pharmacology & Therapeutics, 2026
- Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )Alimentary Pharmacology & Therapeutics, 2026
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated SteatohepatitisNew England Journal of Medicine, 2025
- Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyHepatology, 2025
- MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analysesAlimentary Pharmacology & Therapeutics, 2023
- Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual ParticipantsGastroenterology, 2022
- Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology, 2022
- Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASHHepatology, 2020